BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2017

May 9, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2017-05-05

Reporting Person: Ajer Jeffrey Robert (EVP, Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-05-05	Common Stock	M	988	$28.23	Acquired	52520	Direct
2017-05-05	Common Stock	S	988	$99	Disposed	51532	Direct
2017-05-05	Common Stock	M	3498	$38.59	Acquired	55030	Direct
2017-05-05	Common Stock	S	3498	$99	Disposed	51532	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-05-05	Stock Option (Right to buy Common Stock)	$28.23	M	988	Disposed	2021-05-30	Common Stock (988)	Direct
2017-05-05	Stock Option (Right to buy Common Stock)	$38.59	M	3498	Disposed	2018-05-21	Common Stock (3498)	Direct

Footnotes

F1: Trade made pursuant to a 10b5-1 plan executed on August 18, 2016.

F2: All shares were sold at the same price.

F3: Reflects the number of stock options outstanding after the transaction from this specific stock option grant.